Fundraising FoxSemnur Pharmaceuticals
4 known investors
Find your way into Semnur Pharmaceuticals
Sign up to see every warm intro you have to Semnur Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Semnur Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sorrento Therapeutics is a biotechnology and life sciences company that develops therapeutics and technologies through in-house programs, acquisitions, and mergers. Its portfolio spans areas including antibody-drug conjugates, cell therapy, and lymphatic drug delivery systems.
Founders & leadership
Investors · 4
How we know: Aisling Capital's portfolio page · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$100M disclosed across 1 round · 2026
- $100MraisedJul 2026 · 4 sources
iHolding Group LLP
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2014 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2014 | $586.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $224.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2014 | $224.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2012 | $597.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2011 | $598.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2010 | $600K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Semnur Pharmaceuticals do?
- Sorrento Therapeutics is a biotechnology and life sciences company that develops therapeutics and technologies through in-house programs, acquisitions, and mergers. Its portfolio spans areas including antibody-drug conjugates, cell therapy, and lymphatic drug delivery systems.
- Who founded Semnur Pharmaceuticals?
- Semnur Pharmaceuticals was founded by Henry Ji.
- Who are Semnur Pharmaceuticals's investors?
- Semnur Pharmaceuticals's investors include Aisling Capital, Canaan Partners, Frazier Life Sciences.
- How much funding has Semnur Pharmaceuticals raised?
- Semnur Pharmaceuticals has disclosed $100M raised across 1 round.